Tuesday, February 07, 2017
Based on the success of previous three World- China Biosimilars forums as well as two Biopharmaceutical Innovation and Development Symposiums, International Biopharmaceutical Conference 2017 (BioCon2017) will be held on March 24-25, 2017, Shanghai, China.
Biocon Conference consisted of 4th World-China Biosimilars Forum (Host:BMAP Global; Co-organizer:Shanghai Henlius Biotech) and 3rd International Symposium on Biopharmaceutical Innovation and Development (Host:BMAP Global; Organizer:Shanghai Jiao Tong University Engineering Research Center of Cell & Therapeutic Antibody, MOE).
Regarded content as rudder, speakers' practical speech as blade, importing latest technology as buoy, accelerating industrialization as the arrival of the port, Biocon 2017 sincerely present the Biopharmaceutical Feast to you!
Reply email (biocon@bmapglobal.com) to get the detailed agenda, super early bird discount ends 15 February.
4th World-China Biosimilars Forum
Host: BMAP Global Co., Ltd.
Co-organizer: Shanghai Henlius Biotech
Why you should attend?
3rd International Symposium on Biopharmaceutical Innovation and Development
Why you should attend?
We've got a very impressive list of speakers including:
Steve Drew, Member of National Academy of Engineering, USA;
Katrin Rupalla, China Head Development, Bristol-Myers Squibb;
Jianwei Zhu,Chair Professor, Shanghai Jiao Tong University;
Lianshan Zhang, President of global R&D at Jiangsu Hengrui Medicine;
Li Chen,CEO, Hua Medicine;
Jianmin Fang, CSO, Remegen Biopharmaceutical;
Feng Li, CEO, Beijing Mab-Works;
Tianlei Ying, Professor of Fudan University;
Dan Zhang, CEO of Fountain Medical Development;
Haiping Zhou, Executive Director, Beijing Eastern Biotech.
Ho Yeong (Paul) Song,Vice President and Head of Cell Engineering Team,Samsung Bioepis, South Korea;
Byoung Oh Kwon,Head of Downstream Process Development Department, R&D, Celltrion;
Jianwei Zhu,Shanghai Jiao Tong University;
Scott Liu CEO Shanghai Henlius Biotech;
Lianshan Zhang,President of global R&D at Jiangsu Hengrui Medicine;
Jacqueline Huang, Medical Development Director at Amgen China;
Yuanguo Cheng, National Shanghai Center for New Drug Safety Evaluation and Research;
Youling Wu, CEO, Teruisi Pharmaceutical;
Shengfeng Li, CEO, Bio-Thera Solutions, Ltd.;
Hungfai Poon, CSO, Zhejiang Hisun Pharmaceutical;
Yanzhuo Wu, VP, Beijing Sl Pharmaceutical;
Hongyan Xie,Head of Healthcare Application Solutions, GE;
Tianlei Ying, Professor of Fudan University;
BioCon2017 aims to create a platform for the representatives from companies, institutes and universities in biopharmaceutical field to communicate with each other. With the common efforts, we believe BioCon 2017 will be successful and wonderful.
Contact Information:
Tel: +86 021-6052 9512
Email: biocon@bmapglobal.com
Website: http://www.bmapglobal.com/biocon2017/#
